Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Exact Sciences (EXAS) Tops Q3 EPS by 10c, FY Revenue Guidance Misses at Mid-Point
October 29, 2019 4:11 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.31), $0.10 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $218.8 million versus the consensus estimate of $216.11 million.
GUIDANCE:
Exact Sciences sees FY2019 revenue of $802-810 million, versus the consensus of... More
